ad image

X4 Pharmaceuticals

1 / 1
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

PAO-06-022--RT-01Jun 24, 2022
Q: What important company milestone do you anticipate reaching in 2022?
Milestones

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac

PAO-03-022-RT-01Mar 11, 2022
X4 Pharmaceuticals
Clinical Data

X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021

X4 Pharmaceuticals

PR-M06-21-025Jun 21, 2021
X4 Pharmaceuticals
Clinical Data

X4 Pharmaceuticals Presents Clinical Data Demonstrating Combinability of X4P-001-IO and Opdivo® (nivolumab) in Patients with Clear Cell Renal Cell Carcinoma

X4 Pharmaceuticals

PR-M05-18-NI-068May 17, 2018
1 / 1